CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
Cesana C
Bone Marrow Transplant. 21(6):561-8.
The parallel between CD45 expression and extra-medullary evolution in aggressive myeloma with high serum lactate dehydrogenase.
Cesana C
Haematologica. 83(3):276-9.
Biologic and phenotypic analysis of early hematopoietic progenitor cells in umbilical cord blood.
Almici C
Leukemia. 11(12):2143-9.
Retroviral transfer of herpes simplex virus-thymidine kinase and beta-galactosidase genes into U937 cells with bicistronic vector.
Di Ianni M
Leuk Res. 21(10):951-9.
Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
Carlo-Stella C
Bone Marrow Transplant. 20(6):465-71.
Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C
Haematologica. 82(3):291-6.
Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation.
Almici C
Bone Marrow Transplant. 19(11):1079-84.
In vitro growth of mobilized peripheral blood progenitor cells is significantly enhanced by stem cell factor.
Cesana C
Stem Cells. 15(3):207-13.
Arachidonic acid mediates interleukin-1 and tumor necrosis factor-alpha-induced activation of the c-jun amino-terminal kinases in stromal cells.
Rizzo MT, Carlo-Stella C
Blood. 88(10):3792-800.
Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.
Carlo-Stella C
Blood. 88(8):3091-100.